Investors Capital Advisory Services - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Investors Capital Advisory Services ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2015$14,000
-51.7%
10,000
-33.3%
0.00%
-40.0%
Q2 2015$29,000
-21.6%
15,000
-28.2%
0.01%
-28.6%
Q1 2015$37,000
+8.8%
20,900
+42.2%
0.01%
+16.7%
Q4 2014$34,000
-17.1%
14,700
-13.3%
0.01%
-25.0%
Q3 2014$41,000
-8.9%
16,950
+3.7%
0.01%
+14.3%
Q2 2014$45,00016,3500.01%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2015
NameSharesValueWeighting ↓
EAGLE ASSET MANAGEMENT INC 15,707,022$38,010,0000.11%
First Heartland Consultants, Inc. 74,624$181,0000.08%
WASHINGTON TRUST Co 410,616$994,0000.07%
Geduld E E 40,000$97,0000.07%
FIRST NEW YORK SECURITIES LLC /NY 30,562$73,960,0000.05%
Crosspoint Capital Strategies, LLC 25,000$61,0000.04%
JANE STREET GROUP, LLC 1,434,975$3,473,0000.04%
MAGEE THOMSON INVESTMENT PARTNERS LLC 21,479$51,0000.01%
TIAA CREF TRUST CO FSB/MO 296,322$717,0000.01%
Investors Capital Advisory Services 16,950$41,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders